Trial record 1 of 1 for:
BYON4228.001
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05737628 |
Recruitment Status :
Recruiting
First Posted : February 21, 2023
Last Update Posted : March 20, 2024
|
Sponsor:
Byondis B.V.
Information provided by (Responsible Party):
Byondis B.V.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | October 1, 2024 |
Estimated Study Completion Date : | December 1, 2025 |